Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response

Abstract Background To evaluate the predictive value of the lipiodol retention pattern for local progression of HCC with a complete response (CR) on CT according to mRECIST criteria after a first session of conventional chemoembolization (cTACE). Methods From January 2014 to May 2016 all consecutive...

Full description

Bibliographic Details
Main Authors: Marco Dioguardi Burgio, Riccardo Sartoris, Claudia Libotean, Magaly Zappa, Annie Sibert, Valérie Vilgrain, Maxime Ronot
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Cancer Imaging
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40644-019-0260-2
id doaj-e6f54bac0d2a40daa668cce9cfa4c726
record_format Article
spelling doaj-e6f54bac0d2a40daa668cce9cfa4c7262021-04-02T18:02:32ZengBMCCancer Imaging1470-73302019-11-011911910.1186/s40644-019-0260-2Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete responseMarco Dioguardi Burgio0Riccardo Sartoris1Claudia Libotean2Magaly Zappa3Annie Sibert4Valérie Vilgrain5Maxime Ronot6Department of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineDepartment of Radiology, APHP, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-SeineAbstract Background To evaluate the predictive value of the lipiodol retention pattern for local progression of HCC with a complete response (CR) on CT according to mRECIST criteria after a first session of conventional chemoembolization (cTACE). Methods From January 2014 to May 2016 all consecutive patients undergoing a first cTACE session for HCC were identified. Inclusion criteria were the presence of ≤3 HCCs and available pre- and post-cTACE CT. Tumor response was classified according to mRECIST criteria. The analysis focused on tumors with a CR. The lipiodol retention pattern in these tumors was classified as complete (C-Lip, covering the entire tumor volume), or incomplete (I-Lip). Local progression was defined as the reappearance of areas of enhancement on arterial-phase images with washout on portal/delayed phase images within 2 cm from treated tumors on follow-up CT. Results The final population included 50 patients with 82 HCCs. A total of 46 (56%) HCCs were classified with a CR, including 16 (35%) with I-Lip, and 30 (65%) with C-Lip. After a median follow-up of 14 months (3.2–35.9 months), 15/16 (94%) and 10/30 (30%) of I-Lip and C-Lip HCCs showed local progression on CT, respectively (p < 0.001), with no significant difference in the time to progression (mean 11.1 ± 2 vs. 13.4 ± 3 months for I-Lip and C-Lip, respectively p = 0.51). Conclusions HCCs with incomplete lipiodol retention after a first cTACE session have a high risk of local progression even when there is a CR according to mRECIST, and should be considered to be incompletely treated.http://link.springer.com/article/10.1186/s40644-019-0260-2Carcinoma, hepatocellularEthiodized oilChemoembolization, therapeutic
collection DOAJ
language English
format Article
sources DOAJ
author Marco Dioguardi Burgio
Riccardo Sartoris
Claudia Libotean
Magaly Zappa
Annie Sibert
Valérie Vilgrain
Maxime Ronot
spellingShingle Marco Dioguardi Burgio
Riccardo Sartoris
Claudia Libotean
Magaly Zappa
Annie Sibert
Valérie Vilgrain
Maxime Ronot
Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
Cancer Imaging
Carcinoma, hepatocellular
Ethiodized oil
Chemoembolization, therapeutic
author_facet Marco Dioguardi Burgio
Riccardo Sartoris
Claudia Libotean
Magaly Zappa
Annie Sibert
Valérie Vilgrain
Maxime Ronot
author_sort Marco Dioguardi Burgio
title Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
title_short Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
title_full Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
title_fullStr Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
title_full_unstemmed Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
title_sort lipiodol retention pattern after tace for hcc is a predictor for local progression in lesions with complete response
publisher BMC
series Cancer Imaging
issn 1470-7330
publishDate 2019-11-01
description Abstract Background To evaluate the predictive value of the lipiodol retention pattern for local progression of HCC with a complete response (CR) on CT according to mRECIST criteria after a first session of conventional chemoembolization (cTACE). Methods From January 2014 to May 2016 all consecutive patients undergoing a first cTACE session for HCC were identified. Inclusion criteria were the presence of ≤3 HCCs and available pre- and post-cTACE CT. Tumor response was classified according to mRECIST criteria. The analysis focused on tumors with a CR. The lipiodol retention pattern in these tumors was classified as complete (C-Lip, covering the entire tumor volume), or incomplete (I-Lip). Local progression was defined as the reappearance of areas of enhancement on arterial-phase images with washout on portal/delayed phase images within 2 cm from treated tumors on follow-up CT. Results The final population included 50 patients with 82 HCCs. A total of 46 (56%) HCCs were classified with a CR, including 16 (35%) with I-Lip, and 30 (65%) with C-Lip. After a median follow-up of 14 months (3.2–35.9 months), 15/16 (94%) and 10/30 (30%) of I-Lip and C-Lip HCCs showed local progression on CT, respectively (p < 0.001), with no significant difference in the time to progression (mean 11.1 ± 2 vs. 13.4 ± 3 months for I-Lip and C-Lip, respectively p = 0.51). Conclusions HCCs with incomplete lipiodol retention after a first cTACE session have a high risk of local progression even when there is a CR according to mRECIST, and should be considered to be incompletely treated.
topic Carcinoma, hepatocellular
Ethiodized oil
Chemoembolization, therapeutic
url http://link.springer.com/article/10.1186/s40644-019-0260-2
work_keys_str_mv AT marcodioguardiburgio lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse
AT riccardosartoris lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse
AT claudialibotean lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse
AT magalyzappa lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse
AT anniesibert lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse
AT valerievilgrain lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse
AT maximeronot lipiodolretentionpatternaftertaceforhccisapredictorforlocalprogressioninlesionswithcompleteresponse
_version_ 1721552692024705024